Search Results
Immune-Related Adverse Events for Endocrine Toxicities - Diabetes Mellitus
Grades severity of hyperglycemia secondary to immune checkpoint inhibitor therapy.Hyperglycemia severity (ICPi therapy).
Diabetes Care in the Hospital
Based on guidelines from the American Diabetes Association.Based on guidelines from the ADA.
American Diabetes Association (ADA) Risk Calculator
Predicts risk of undiagnosed diabetes to determine who should be screened.T2DM risk.
Cambridge Diabetes Risk Score
Predicts risk of having previously undiagnosed type 2 diabetes.T2DM risk.
Canadian Diabetes Risk Assessment Questionnaire (CANRISK)
Screens for undiagnosed type 2 diabetes mellitus and prediabetes.T2D and prediabetes screening.
Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool
Estimates risk of developing type 2 diabetes, mainly in Australian patients.Estimates diabetes risk.
Diabetes Distress Scale (DDS17)
Evaluates diabetes-related emotional distress.Diabetes distress.
International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment
Stratifies fasting risk during Ramadan in diabetic patients.Fasting risk during Ramadan.
BeAM Value
Calculates the difference between bedtime and AM fasting glucoses.Bedtime vs. AM glucose.
Estimated Average Glucose (eAG) From HbA1C
Estimates an average glucose level from Hemoglobin A1C value.Estimates avg gluc from HbA1C.
Glucose Infusion Rate (GIR)
Quantifies the rate at which glucose is administered intravenously.Intravenous glucose administration rate.
FINDRISC (Finnish Diabetes Risk Score)
Identifies patients at high risk for type 2 diabetes.T2DM risk.
ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC
Determine 10-year risk of hard ASCVD, i.e. myocardial infarction, stroke, or death due to coronary heart disease or stroke.10-year heart disease or stroke risk.
ASCVD (Atherosclerotic Cardiovascular Disease) Risk Algorithm including Known ASCVD from AHA/ACC
Determines 10-year risk of hard ASCVD, i.e. myocardial infarction, stroke, or death due to coronary heart disease or stroke, and provides statin recommendations.10-year heart disease or stroke risk and statin recommendations.
C-Peptide to Glucose Ratio
Assesses beta cell secretory function in patients with diabetes/prediabetes.Beta cell secretory function.
Charlson Comorbidity Index (CCI)
Predicts 10-year survival in patients with multiple comorbidities.10-year survival.
Diabetic Ketoacidosis Mortality Prediction Model (DKA MPM) Score
Predicts in-hospital mortality in DKA.In-hospital DKA mortality.
HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)
Approximates insulin resistance.Approximates insulin resistance.
Hypoglycemia Risk Score
Predicts 12-month risk of hypoglycemic episodes in T2DM patients.Hypoglycemia prediction.
Metabolic Score for Insulin Resistance (METS-IR)
Predicts risk of type 2 diabetes in previously undiagnosed patients.Type 2 diabetes risk.
Sodium Correction for Hyperglycemia
Calculates the actual sodium level in patients with hyperglycemia.Calculates Na in hyperglycemia.
Adverse Childhood Experiences (ACE) Score
Screens for adverse childhood experiences.ACE screening.
APACHE II Score
Estimates ICU mortality.Estimates ICU mortality.
BARD Score for NAFLD Fibrosis
Predicts risk of advanced fibrosis in NAFLD patients.Advanced fibrosis risk.
Berg Balance Scale (BBS)
Assesses balance and risk for falls in older community-dwelling adults.Balance and fall risk in older adults.
Contact us